T1	AdverseReaction 113 131	acute pancreatitis
T2	AdverseReaction 272 298	hypersensitivity reactions
T3	Severity 264 271	serious
T4	AdverseReaction 339 350	anaphylaxis
T5	AdverseReaction 352 362	angioedema
T6	AdverseReaction 374 401	cutaneous adverse reactions
T7	Severity 367 373	severe
T8	AdverseReaction 633 648	hepatic failure
T9	AdverseReaction 660 665	fatal
T10	AdverseReaction 1222 1232	arthralgia
T11	Severity 1201 1207	Severe
T12	Severity 1212 1221	disabling
T13	AdverseReaction 1634 1652	acute pancreatitis
T14	AdverseReaction 2132 2158	hypersensitivity reactions
T15	Severity 2124 2131	serious
T16	AdverseReaction 2216 2227	anaphylaxis
T17	AdverseReaction 2229 2239	angioedema
T18	AdverseReaction 2251 2278	cutaneous adverse reactions
T19	Severity 2244 2250	severe
T20	AdverseReaction 2290 2314	Stevens-Johnson syndrome
T21	AdverseReaction 2782 2797	hepatic failure
T22	Severity 2773 2781	nonfatal
T23	AdverseReaction 2763 2768	fatal
T24	AdverseReaction 2996 3026;3033 3043	serum alanine aminotransferase elevations
T29	AdverseReaction 4540 4550	arthralgia
T30	Severity 4530 4539	disabling
T31	Severity 4519 4525	severe
T32	DrugClass 4570 4586	DPP-4 inhibitors
T33	Severity 3057 3100	three times the upper limit of normal (ULN)
T34	DrugClass 1270 1286	DPP-4 inhibitors
T35	AdverseReaction 3028 3031;3033 3043	ALT elevations
T36	AdverseReaction 959 971	Hypoglycemia
T37	AdverseReaction 52 70	Acute pancreatitis
T38	AdverseReaction 205 221	Hypersensitivity
T39	AdverseReaction 591 606	Hepatic effects
T40	AdverseReaction 1189 1199	Arthralgia
E1	AdverseReaction:T1
E2	AdverseReaction:T2 Effect:E3
E3	Severity:T3
E4	AdverseReaction:T4
E5	AdverseReaction:T5
E6	AdverseReaction:T6 Effect:E7
E7	Severity:T7
E8	AdverseReaction:T8
E9	AdverseReaction:T9
E11	AdverseReaction:T10 Effect:E12 Effect2:E13 Hypothetical:E30
E12	Severity:T11
E13	Severity:T12
E14	AdverseReaction:T13
E15	AdverseReaction:T14 Effect:E16
E16	Severity:T15
E17	AdverseReaction:T16
E18	AdverseReaction:T17
E19	AdverseReaction:T18 Effect:E20
E20	Severity:T19
E21	AdverseReaction:T20
E22	AdverseReaction:T21 Effect:E23
E23	Severity:T22
E24	AdverseReaction:T23
E25	AdverseReaction:T24 Effect:E35
E31	Severity:T30
E32	Severity:T31
E33	AdverseReaction:T29 Effect:E32 Hypothetical:E34 Effect2:E31
E34	DrugClass:T32
E10	AdverseReaction:T21
E35	Severity:T33
E30	DrugClass:T34
E36	AdverseReaction:T35 Effect:E35
E37	AdverseReaction:T36
E38	AdverseReaction:T37
E39	AdverseReaction:T38
E40	AdverseReaction:T39
E41	AdverseReaction:T40
A1	CUI E1 C0001339
A2	UMLS-Preferred-Name E1 Acute pancreatitis
A3	MEDDRA-PT E1 Pancreatitis acute
A4	MEDDRA-PT-ID E1 10033647
A5	LLT E1 Acute pancreatitis
A6	LLT-ID E1 10000971
A7	CUI E2 C0020517
A8	UMLS-Preferred-Name E2 Hypersensitivity
A9	MEDDRA-PT E2 Hypersensitivity
A10	MEDDRA-PT-ID E2 10020751
A11	LLT E2 Hypersensitivity reaction
A12	LLT-ID E2 10020756
A13	CUI E4 C0002792
A14	UMLS-Preferred-Name E4 anaphylaxis
A15	MEDDRA-PT E4 Anaphylactic reaction
A16	MEDDRA-PT-ID E4 10002198
A17	LLT E4 Anaphylaxis
A18	LLT-ID E4 10002218
A19	CUI E5 C0002994
A20	UMLS-Preferred-Name E5 Angioedema
A21	MEDDRA-PT E5 Angioedema
A22	MEDDRA-PT-ID E5 10002424
A23	CUI E6 C0221743
A24	UMLS-Preferred-Name E6 Skin reaction
A25	MEDDRA-PT E6 Skin reaction
A26	MEDDRA-PT-ID E6 10040914
A27	CUI E8 C0085605
A28	UMLS-Preferred-Name E8 Liver Failure
A29	MEDDRA-PT E8 Hepatic failure
A30	MEDDRA-PT-ID E8 10019663
A31	CUI E9 C1306577
A32	UMLS-Preferred-Name E9 Death (finding)
A33	MEDDRA-PT E9 Death
A34	MEDDRA-PT-ID E9 10011906
A35	CUI E11 C0003862
A36	UMLS-Preferred-Name E11 Arthralgia
A37	MEDDRA-PT E11 Arthralgia
A38	MEDDRA-PT-ID E11 10003239
A39	CUI E14 C0001339
A40	UMLS-Preferred-Name E14 Acute pancreatitis
A41	MEDDRA-PT E14 Pancreatitis acute
A42	MEDDRA-PT-ID E14 10033647
A43	LLT E14 Acute pancreatitis
A44	LLT-ID E14 10000971
A45	CUI E15 C0020517
A46	UMLS-Preferred-Name E15 Hypersensitivity
A47	MEDDRA-PT E15 Hypersensitivity
A48	MEDDRA-PT-ID E15 10020751
A49	LLT E15 Hypersensitivity reaction
A50	LLT-ID E15 10020756
A51	CUI E17 C0002792
A52	UMLS-Preferred-Name E17 anaphylaxis
A53	MEDDRA-PT E17 Anaphylactic reaction
A54	MEDDRA-PT-ID E17 10002198
A55	LLT E17 Anaphylaxis
A56	LLT-ID E17 10002218
A57	CUI E18 C0002994
A58	UMLS-Preferred-Name E18 Angioedema
A59	MEDDRA-PT E18 Angioedema
A60	MEDDRA-PT-ID E18 10002424
A61	CUI E19 C0221743
A62	UMLS-Preferred-Name E19 Skin reaction
A63	MEDDRA-PT E19 Skin reaction
A64	MEDDRA-PT-ID E19 10040914
A65	CUI E21 C0038325
A66	UMLS-Preferred-Name E21 Stevens-Johnson Syndrome
A67	MEDDRA-PT E21 Stevens-Johnson syndrome
A68	MEDDRA-PT-ID E21 10042033
A69	CUI E22 C0085605
A70	UMLS-Preferred-Name E22 Liver Failure
A71	MEDDRA-PT E22 Hepatic failure
A72	MEDDRA-PT-ID E22 10019663
A73	CUI E24 C1306577
A74	UMLS-Preferred-Name E24 Death (finding)
A75	MEDDRA-PT E24 Death
A76	MEDDRA-PT-ID E24 10011906
A77	CUI E25 C0151905
A78	UMLS-Preferred-Name E25 Alanine aminotransferase increased
A79	MEDDRA-PT E25 Alanine aminotransferase increased
A80	MEDDRA-PT-ID E25 10001551
A81	CUI E33 C0003862
A82	UMLS-Preferred-Name E33 Arthralgia
A83	MEDDRA-PT E33 Arthralgia
A84	MEDDRA-PT-ID E33 10003239
A85	CUI E36 C0151905
A86	UMLS-Preferred-Name E36 Alanine aminotransferase increased
A87	MEDDRA-PT E36 Alanine aminotransferase increased
A88	MEDDRA-PT-ID E36 10001551
A89	LLT E36 ALT increased
A90	LLT-ID E36 10001845
A91	CUI E37 C0020615
A92	UMLS-Preferred-Name E37 Hypoglycemia
A93	MEDDRA-PT E37 Hypoglycaemia
A94	MEDDRA-PT-ID E37 10020993
A95	LLT E37 Hypoglycemia
A96	LLT-ID E37 10021005
A97	CUI E38 C0001339
A98	UMLS-Preferred-Name E38 Acute pancreatitis
A99	MEDDRA-PT E38 Pancreatitis acute
A100	MEDDRA-PT-ID E38 10033647
A101	LLT E38 Acute pancreatitis
A102	LLT-ID E38 10000971
A103	CUI E39 C0020517
A104	UMLS-Preferred-Name E39 Hypersensitivity
A105	MEDDRA-PT E39 Hypersensitivity
A106	MEDDRA-PT-ID E39 10020751
A107	CUI E40 C0235378
A108	UMLS-Preferred-Name E40 Hepatotoxicity
A109	MEDDRA-PT E40 Hepatotoxicity
A110	MEDDRA-PT-ID E40 10019851
A111	LLT E40 Hepatotoxic effect
A112	LLT-ID E40 10019850
A113	CUI E41 C0003862
A114	UMLS-Preferred-Name E41 Arthralgia
A115	MEDDRA-PT E41 Arthralgia
A116	MEDDRA-PT-ID E41 10003239
